BDBM698818 (2-((1- ((dimethylamino)methyl)cyclopropyl) methoxy)-4-(2-(hydroxymethyl) azepan-1-yl)-5,7-dihydro-6H-pyrrolo [3,4-d]pyrimidin-6-yl)(3-hydroxy-8- iodonaphthalen-1-yl)methanone::US20240317759, Example 28

SMILES CN(C)C1CCN(c2ccc(Nc3nc(NC4CCOCC4)c(-c4ccccc4)nc3C(N)=O)cc2)CC1

InChI Key InChIKey=YFGWYCBHTXOWFT-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 698818   

TargetEpidermal growth factor receptor(Human)
Wigen Biomedicine Technology (Shanghai) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698818BDBM698818(US12600714, Compound 59)
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2026
Entry Details
US Patent